| Entry |
|
|---|
| Name |
Gold sodium thiomalate (USP);
Sodium aurothiomalate (JP18);
Myochrysine (TN) |
|---|
| Formula |
C4H3AuO4S. xNa. (2-x)H
|
|---|
| Structure |
|
|---|
| Class |
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01912 Gold preparations
|
|---|
| Remark |
| Therapeutic category: | 4420 |
|
|---|
| Efficacy |
Antirheumatic |
|---|
| Interaction |
|
|---|
| Structure map |
| map07050 | Antirheumatics - DMARDs and biological agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01C SPECIFIC ANTIRHEUMATIC AGENTS
M01CB Gold preparations
M01CB01 Sodium aurothiomalate
D00992 Gold sodium thiomalate (USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
442 Stimulation therapy agents
4420 Stimulation therapy agents
D00992 Gold sodium thiomalate (USP); Sodium aurothiomalate (JP18)
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01912 Gold preparations
D00992 Gold sodium thiomalate
Drug classes [BR:br08332]
Antirheumatic agent
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D00992 Gold sodium thiomalate
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00992 Sodium aurothiomalate
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C1c C 17.4192 -17.1543
2 C1b C 16.2035 -16.4533
3 C6a C 18.6289 -16.4533
4 S2a S 17.4192 -18.5570
5 C6a C 14.9925 -17.1543
6 O6a O 18.6289 -15.0566
7 O6a O 19.8444 -17.1543 #-
8 Z Au 18.6289 -19.2533
9 O6a O 14.9925 -18.5570
10 O6a O 13.7827 -16.4533 #-
11 Z Na 23.1360 -17.1945 #+
BOND 9
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 3 7 1
7 4 8 1
8 5 9 2
9 5 10 1
BRACKET 1 22.3300 -18.2700 22.3300 -15.7500
1 24.7100 -15.7500 24.7100 -18.2700
1 x
ORIGINAL 1 11
REPEAT 1
2 27.2300 -18.4800 27.2300 -15.8900
2 29.4000 -15.8900 29.4000 -18.4800
2 2-x
ORIGINAL 2 12
REPEAT 2
|
|---|
